Hospital Medicine and Economics Centers for Education & Research for Therapeutics

医院医学和经济教育中心

• 批准号: 7497518
• 负责人: DAVID O MELTZER
• 金额: $ 98.83万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-18 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7497518
• 关键词: Hospital; Medicine; Economics; Centers; Education

DESCRIPTION (Provided by the Applicant): Hospitals are the site of intensive use of drugs, biological products, and devices, with a major impact on both the outcome and cost of care. In the past decade, hospital care has begun a major transformation through the increasing use of clinical information systems and systematic approaches to improving safety and quality, and the rapid growth in the number of physicians specializing in hospital care, including intensivists and hospitalists. In the next decade, new basic and translational technologies, such as pharmacogenomics and clinical informatics, hold promise to bring a new era of personalized medicine to the hospital setting. This makes the production and dissemination of knowledge about the effective and cost-effective use of hospital therapeutics especially timely and important. The purpose of this application is to request support to establish a Center for Education and Research on Therapeutics (CERT) focused on hospital medicine with a major methodological focus on clinical economics. These are identified in the CERT Funding Opportunity Announcement (FOA) as high priority areas. In addition, there will be a secondary focus on personalized medicine, another high-priority area. The overall aim of the Hospital Medicine and Economics CERT will be to create a powerful education and research infrastructure to produce and disseminate knowledge to improve the effectiveness and cost-effectiveness of the use of therapeutics in hospitals, including drugs, biological products, and devices. The Hospital Medicine and Economics CERT will be based at the University of Chicago (UC), which has unique qualifications in both hospital medicine research and in clinical economics, as well as in personalized medicine. The Hospital Medicine and Economics CERT will also benefit from the participation of the University of Illinois-Chicago (UIC) School of Pharmacy, which already collaborates with UC and AHRQ in this area through the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. In addition, the Hospital Medicine and Economics CERT will benefit from collaboration with Consorta, Inc, a national network of over 500 hospitals, and the ability to draw upon a pre-existing multicenter hospital medicine research group led by UC (including investigators at Brigham and Women's Hospital, the University of California-San Francisco, the University of Iowa, and the University of Wisconsin). The Hospital Medicine and Economics CERT will also gain national scope and impact through an important partnership with the Society of Hospital Medicine, and through affiliation with the National Opinion Research Center (NORC).

描述（由申请人提供）：医院是药物、生物制品和设备的密集使用场所，对护理结果和费用都有重大影响。 在过去的十年中，通过越来越多地使用临床信息系统和系统方法来提高安全性和质量，以及专门从事医院护理的医生（包括重症医生和住院医生）数量的快速增长，医院护理开始了重大转型。 在接下来的十年中，新的基础技术和转化技术，例如药物基因组学和临床信息学，有望为医院环境带来个性化医疗的新时代。 这使得有关有效且经济有效地使用医院治疗方法的知识的产生和传播尤其及时和重要。 本申请的目的是请求支持建立一个治疗学教育和研究中心 (CERT)，该中心专注于医院医学，其主要方法论重点是临床经济学。 这些在 CERT 资助机会公告 (FOA) 中被确定为高度优先领域。 此外，第二个重点将是个性化医疗，这是另一个高度优先的领域。 医院医学和经济学 CERT 的总体目标是创建强大的教育和研究基础设施，以生产和传播知识，以提高医院使用治疗方法（包括药物、生物制品和设备）的有效性和成本效益。 医院医学和经济学 CERT 将设在芝加哥大学 (UC)，该大学在医院医学研究、临床经济学以及个性化医疗方面拥有独特的资质。 医院医学和经济学 CERT 还将受益于伊利诺伊大学芝加哥分校 (UIC) 药学院的参与，该学院已通过“开发证据以告知有效性决策”(DEcIDE) 计划与 UC 和 AHRQ 在该领域进行合作。 此外，医院医学和经济学 CERT 将受益于与 Consorta, Inc（一个由 500 多家医院组成的全国网络）的合作，以及利用 UC 领导的现有多中心医院医学研究小组（包括布莱根妇女医院、加州大学旧金山分校、爱荷华大学和威斯康星大学的研究人员）的能力。 医院医学和经济学 CERT 还将通过与医院医学协会的重要合作伙伴关系以及与国家意见研究中心 (NORC) 的联系，获得全国范围和影响力。